China, Five Other Nations Eyed In U.S. Drug Maker Bribery Probe
This article was originally published in PharmAsia News
Executive Summary
China is among several nations mentioned in a U.S. probe of major drug companies suspected of paying bribes to officials in other countries to garner favorable treatment
|
China is among several nations mentioned in a U.S. probe of major drug companies suspected of paying bribes to officials in other countries to garner favorable treatment. The U.S. government is investigating possible violations of the U.S. Foreign Corrupt Practices Act, which makes it illegal for firms whose stock is traded in the United States to bribe any government official. The probe conducted by the Justice Department and the Securities and Exchange Commission includes some of the biggest names in the pharmaceutical industry and government officials in China, Brazil, Germany, Italy, Poland, Russia and Saudi Arabia, according to sources. (Click here for more - a subscription may be required) "Drug Firms Face Bribery Probe" - Wall Street Journal (U.S.) (10/5/10) |